메뉴 건너뛰기




Volumn 52, Issue 4, 2011, Pages 794-800

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease

Author keywords

Kinetics; Lipoprotein metabolism; Triglycerides

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN B48; APOLIPOPROTEIN C3; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN TRIGLYCERIDE;

EID: 79953322010     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M011163     Document Type: Article
Times cited : (55)

References (41)
  • 1
    • 4644221457 scopus 로고    scopus 로고
    • Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    • Go, A. S., G. M. Chertow, D. Fan, C. E. McCulloch, and C. Y. Hsu. 2004. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351: 1296-1305.
    • (2004) N. Engl. J. Med. , vol.351 , pp. 1296-1305
    • Go, A.S.1    Chertow, G.M.2    Fan, D.3    McCulloch, C.E.4    Hsu, C.Y.5
  • 2
    • 3042762893 scopus 로고    scopus 로고
    • Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein
    • DOI 10.1111/j.1523-1755.2004.00736.x
    • Busch, M., S. Franke, A. Muller, M. Wolf, J. Gerth, U. Ott, T. Niwa, and G. Stein. 2004. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney Int. 66: 338-347. (Pubitemid 38870111)
    • (2004) Kidney International , vol.66 , Issue.1 , pp. 338-347
    • Busch, M.1    Franke, S.2    Muller, A.3    Wolf, M.4    Gerth, J.5    Ott, U.6    Niwa, T.7    Stein, G.8
  • 3
    • 38149070113 scopus 로고    scopus 로고
    • Hyperlipidemia in chronic kidney disease
    • Kaysen, G. A. 2007. Hyperlipidemia in chronic kidney disease. Int. J. Artif. Organs. 30: 987-992.
    • (2007) Int. J. Artif. Organs , vol.30 , pp. 987-992
    • Kaysen, G.A.1
  • 5
    • 42549109081 scopus 로고    scopus 로고
    • Apolipoprotein C-III: Understanding an emerging cardiovascular risk factor
    • Ooi, E. M., P. H. Barrett, D. C. Chan, and G. F. Watts. 2008. Apolipoprotein C-III: understanding an emerging cardiovascular risk factor. Clin. Sci. (Lond.). 114: 611-624.
    • (2008) Clin. Sci. (Lond.) , vol.114 , pp. 611-624
    • Ooi, E.M.1    Barrett, P.H.2    Chan, D.C.3    Watts, G.F.4
  • 6
    • 0019802626 scopus 로고
    • 2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects
    • Huff, M. W., N. H. Fidge, P. J. Nestel, T. Billington, and B. Watson. 1981. Metabolism of C-apolipoproteins: kinetics of C-II, C-III1 and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects. J. Lipid Res. 22: 1235-1246. (Pubitemid 12173299)
    • (1981) Journal of Lipid Research , vol.22 , Issue.8 , pp. 1235-1246
    • Huff, M.W.1    Fidge, N.H.2    Nestel, P.J.3
  • 8
    • 5444267382 scopus 로고    scopus 로고
    • Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia
    • DOI 10.1016/j.atherosclerosis.2004.06.011, PII S0021915004003648
    • Cohn, J. S., M. Tremblay, R. Batal, H. Jacques, C. Rodriguez, G. Steiner, O. Mamer, and J. Davignon. 2004. Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia. Atherosclerosis. 177: 137-145. (Pubitemid 39361148)
    • (2004) Atherosclerosis , vol.177 , Issue.1 , pp. 137-145
    • Cohn, J.S.1    Tremblay, M.2    Batal, R.3    Jacques, H.4    Rodriguez, C.5    Steiner, G.6    Mamer, O.7    Davignon, J.8
  • 9
    • 38349099256 scopus 로고    scopus 로고
    • Dyslipidaemia and cardiorenal disease: Mechanisms, therapeutic opportunities and clinical trials
    • Chan, D. T., A. B. Irish, G. K. Dogra, and G. F. Watts. 2008. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials. Atherosclerosis. 196: 823-834.
    • (2008) Atherosclerosis , vol.196 , pp. 823-834
    • Chan, D.T.1    Irish, A.B.2    Dogra, G.K.3    Watts, G.F.4
  • 10
    • 70849133524 scopus 로고    scopus 로고
    • Chronic kidney disease delays VLDL-apoB-100 particle catabolism: Potential role of apolipoprotein C-III
    • Chan, D. T., G. K. Dogra, A. B. Irish, E. M. Ooi, P. H. Barrett, D. C. Chan, and G. F. Watts. 2009. Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III. J. Lipid Res. 50: 2524-2531.
    • (2009) J. Lipid Res. , vol.50 , pp. 2524-2531
    • Chan, D.T.1    Dogra, G.K.2    Irish, A.B.3    Ooi, E.M.4    Barrett, P.H.5    Chan, D.C.6    Watts, G.F.7
  • 11
    • 0035897696 scopus 로고    scopus 로고
    • Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)
    • Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J. Am. Med. Assoc. 2001 ; 285: 2486-2497.
    • (2001) J. Am. Med. Assoc. , vol.285 , pp. 2486-2497
  • 12
    • 33744780706 scopus 로고    scopus 로고
    • Use of Intralipid for kinetic analysis of HDL apoC-III: Evidence for a homogeneous kinetic pool of apoC-III in plasma
    • Nguyen, M. N., D. C. Chan, K. P. Dwyer, P. Bolitho, G. F. Watts, and P. H. Barrett. 2006. Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma. J. Lipid Res. 47: 1274-1280.
    • (2006) J. Lipid Res. , vol.47 , pp. 1274-1280
    • Nguyen, M.N.1    Chan, D.C.2    Dwyer, K.P.3    Bolitho, P.4    Watts, G.F.5    Barrett, P.H.6
  • 13
    • 0023814007 scopus 로고
    • Metabolism of apolipoprotein C-III in normolipemic human subjects
    • DOI 10.1016/0021-9150(88)90288-2
    • Malmendier, C. L., J. F. Lontie, G. A. Grutman, and C. Delcroix. 1988. Metabolism of apolipoprotein C-III in normolipemic human subjects. Atherosclerosis. 69: 51-59. (Pubitemid 18003508)
    • (1988) Atherosclerosis , vol.69 , Issue.1 , pp. 51-59
    • Malmendier, C.L.1    Lontie, J.-F.2    Grutman, G.A.3    Delcroix, C.4
  • 14
    • 0022556147 scopus 로고
    • Metabolism of apolipoprotein C
    • Fidge, N. H., and P. J. Nestel. 1986. Metabolism of apolipoprotein C. Methods Enzymol. 129: 443-457.
    • (1986) Methods Enzymol. , vol.129 , pp. 443-457
    • Fidge, N.H.1    Nestel, P.J.2
  • 15
    • 0033027427 scopus 로고    scopus 로고
    • Kinetics and mechanism of exchange of apolipoprotein C-III molecules from very low density lipoprotein particles
    • DOI 10.1016/S0167-4838(99)00009-6, PII S0167483899000096
    • Boyle, K. E., M. C. Phillips, and S. Lund-Katz. 1999. Kinetics and mechanism of exchange of apolipoprotein C-III molecules from very low density lipoprotein particles. Biochim. Biophys. Acta. 1430: 302-312. (Pubitemid 29127226)
    • (1999) Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology , vol.1430 , Issue.2 , pp. 302-312
    • Boyle, K.E.1    Phillips, M.C.2    Lund-Katz, S.3
  • 16
  • 17
    • 0027495159 scopus 로고
    • Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: Further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins
    • Tornoci, L., C. A. Scheraldi, X. Li, H. Ide, I. J. Goldberg, and N. A. Le. 1993. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins. J. Lipid Res. 34: 1793-1803.
    • (1993) J. Lipid Res. , vol.34 , pp. 1793-1803
    • Tornoci, L.1    Scheraldi, C.A.2    Li, X.3    Ide, H.4    Goldberg, I.J.5    Le, N.A.6
  • 18
    • 49649124713 scopus 로고    scopus 로고
    • Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome
    • Ooi, E. M., G. F. Watts, D. C. Chan, M. M. Chen, P. J. Nestel, D. Sviridov, and P. H. Barrett. 2008. Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome. Diabetes Care. 31: 1656-1661.
    • (2008) Diabetes Care , vol.31 , pp. 1656-1661
    • Ooi, E.M.1    Watts, G.F.2    Chan, D.C.3    Chen, M.M.4    Nestel, P.J.5    Sviridov, D.6    Barrett, P.H.7
  • 19
    • 0035994247 scopus 로고    scopus 로고
    • ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure
    • DOI 10.1081/JDI-120006775
    • Kimak, E., and J. Solski. 2002. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure. Ren. Fail. 24: 485-492. (Pubitemid 34913058)
    • (2002) Renal Failure , vol.24 , Issue.4 , pp. 485-492
    • Kimak, E.1    Solski, J.2
  • 20
    • 34548396842 scopus 로고    scopus 로고
    • Lipoprotein metabolism in chronic renal insufficiency
    • Saland, J. M., and H. N. Ginsberg. 2007. Lipoprotein metabolism in chronic renal insufficiency. Pediatr. Nephrol. 22: 1095-1112.
    • (2007) Pediatr. Nephrol. , vol.22 , pp. 1095-1112
    • Saland, J.M.1    Ginsberg, H.N.2
  • 21
    • 0029018057 scopus 로고
    • Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and e
    • Clavey, V., S. Lestavel-Delattre, C. Copin, J. M. Bard, and J. C. Fruchart. 1995. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler. Thromb. Vasc. Biol. 15: 963-971.
    • (1995) Arterioscler. Thromb. Vasc. Biol. , vol.15 , pp. 963-971
    • Clavey, V.1    Lestavel-Delattre, S.2    Copin, C.3    Bard, J.M.4    Fruchart, J.C.5
  • 22
    • 0025950963 scopus 로고
    • Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway
    • Sehayek, E., and S. Eisenberg. 1991. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Biol. Chem. 266: 18259-18267. (Pubitemid 21908074)
    • (1991) Journal of Biological Chemistry , vol.266 , Issue.27 , pp. 18259-18267
    • Sehayek, E.1    Eisenberg, S.2
  • 23
    • 0031450209 scopus 로고    scopus 로고
    • Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor
    • Mann, C. J., A. A. Troussard, F. T. Yen, N. Hannouche, J. Najib, J. C. Fruchart, V. Lotteau, P. Andre, and B. E. Bihain. 1997. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor. J. Biol. Chem. 272: 31348-31354.
    • (1997) J. Biol. Chem. , vol.272 , pp. 31348-31354
    • Mann, C.J.1    Troussard, A.A.2    Yen, F.T.3    Hannouche, N.4    Najib, J.5    Fruchart, J.C.6    Lotteau, V.7    Andre, P.8    Bihain, B.E.9
  • 24
    • 0020045973 scopus 로고
    • An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III
    • Holdsworth, G., J. Stocks, P. Dodson, and D. J. Galton. 1982. An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III. J. Clin. Invest. 69: 932-939.
    • (1982) J. Clin. Invest. , vol.69 , pp. 932-939
    • Holdsworth, G.1    Stocks, J.2    Dodson, P.3    Galton, D.J.4
  • 25
    • 0035128720 scopus 로고    scopus 로고
    • Carbamoylation of amino acids and proteins in uremia
    • Kraus, L. M., and A. P. Kraus, Jr. 2001. Carbamoylation of amino acids and proteins in uremia. Kidney Int. Suppl. 78: S102-S107.
    • (2001) Kidney Int. Suppl. , vol.78
    • Kraus, L.M.1    Kraus Jr., A.P.2
  • 27
    • 77951490605 scopus 로고    scopus 로고
    • Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype
    • Zheng, C., C. Khoo, J. Furtado, and F. M. Sacks. 2010. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation. 121: 1722-1734.
    • (2010) Circulation , vol.121 , pp. 1722-1734
    • Zheng, C.1    Khoo, C.2    Furtado, J.3    Sacks, F.M.4
  • 28
    • 0017330684 scopus 로고
    • Very low density lipoprotein. Dissociation of apolipoprotein C during lipoprotein lipase induced lipolysis
    • Glangeaud, M. C., S. Eisenberg, and T. Olivecrona. 1976. Very low density lipoprotein. Dissociation of apolipoprotein C during lipoprotein lipase induced lipolysis. Biochim. Biophys. Acta. 486: 23-35.
    • (1976) Biochim. Biophys. Acta , vol.486 , pp. 23-35
    • Glangeaud, M.C.1    Eisenberg, S.2    Olivecrona, T.3
  • 29
    • 0028881810 scopus 로고
    • Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia
    • Li, W. W., M. M. Dammerman, J. D. Smith, S. Metzger, J. L. Breslow, and T. Leff. 1995. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J. Clin. Invest. 96: 2601-2605.
    • (1995) J. Clin. Invest. , vol.96 , pp. 2601-2605
    • Li, W.W.1    Dammerman, M.M.2    Smith, J.D.3    Metzger, S.4    Breslow, J.L.5    Leff, T.6
  • 30
    • 0027967732 scopus 로고
    • Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: Correlation with changes in plasma triglyceride levels
    • Chen, M., J. L. Breslow, W. Li, and T. Leff. 1994. Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels. J. Lipid Res. 35: 1918-1924. (Pubitemid 24353064)
    • (1994) Journal of Lipid Research , vol.35 , Issue.11 , pp. 1918-1924
    • Chen, M.1    Breslow, J.L.2    Li, W.3    Leff, T.4
  • 31
    • 0035786906 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptors: From genes to physiology
    • Kliewer, S. A., H. E. Xu, M. H. Lambert, and T. M. Willson. 2001. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog. Horm. Res. 56: 239-263.
    • (2001) Recent Prog. Horm. Res. , vol.56 , pp. 239-263
    • Kliewer, S.A.1    Xu, H.E.2    Lambert, M.H.3    Willson, T.M.4
  • 32
    • 0028998129 scopus 로고
    • Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III
    • Hertz, R., J. Bishara-Shieban, and J. Bar-Tana. 1995. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J. Biol. Chem. 270: 13470-13475.
    • (1995) J. Biol. Chem. , vol.270 , pp. 13470-13475
    • Hertz, R.1    Bishara-Shieban, J.2    Bar-Tana, J.3
  • 33
    • 0028817459 scopus 로고
    • Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates
    • Staels, B., N. Vu-Dac, V. A. Kosykh, R. Saladin, J. C. Fruchart, J. Dallongeville, and J. Auwerx. 1995. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest. 95: 705-712.
    • (1995) J. Clin. Invest. , vol.95 , pp. 705-712
    • Staels, B.1    Vu-Dac, N.2    Kosykh, V.A.3    Saladin, R.4    Fruchart, J.C.5    Dallongeville, J.6    Auwerx, J.7
  • 34
    • 39049083945 scopus 로고    scopus 로고
    • Plasma Apolipoprotein C-III Transport in central obese men: Associations with very-low density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism
    • Chan, D. C., M. N. Nguyen, G. F. Watts, and P. H. Barrett. 2008. Plasma Apolipoprotein C-III Transport in central obese men: associations with very-low density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism. J. Clin. Endocrinol. Metab. 93: 557-564.
    • (2008) J. Clin. Endocrinol. Metab. , vol.93 , pp. 557-564
    • Chan, D.C.1    Nguyen, M.N.2    Watts, G.F.3    Barrett, P.H.4
  • 35
    • 34248343423 scopus 로고    scopus 로고
    • Characterization of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation
    • Wong, K., and R. O. Ryan. 2007. Characterization of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation. Curr. Opin. Lipidol. 18: 319-324.
    • (2007) Curr. Opin. Lipidol. , vol.18 , pp. 319-324
    • Wong, K.1    Ryan, R.O.2
  • 37
    • 33748507076 scopus 로고    scopus 로고
    • The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: Prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II
    • Talmud, P. J., J. A. Cooper, H. Hattori, I. P. Miller, G. J. Miller, and S. E. Humphries. 2006. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. Diabetologia. 49: 2337-2340.
    • (2006) Diabetologia , vol.49 , pp. 2337-2340
    • Talmud, P.J.1    Cooper, J.A.2    Hattori, H.3    Miller, I.P.4    Miller, G.J.5    Humphries, S.E.6
  • 38
    • 3142581525 scopus 로고    scopus 로고
    • ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglycerides (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis
    • DOI 10.1074/jbc.M403240200
    • Schaap, F. G., P. C. Rensen, P. J. Voshol, C. Vrins, H. N. van der Vliet, R. A. Chamuleau, L. M. Havekes, A. K. Groen, and K. W. van Dijk. 2004. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein- triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J. Biol. Chem. 279: 27941-27947. (Pubitemid 38900062)
    • (2004) Journal of Biological Chemistry , vol.279 , Issue.27 , pp. 27941-27947
    • Schaap, F.G.1    Rensen, P.C.N.2    Voshol, P.J.3    Vrins, C.4    Van Der, V.H.N.5    Chamuleau, R.A.F.M.6    Havekes, L.M.7    Groen, A.K.8    Van Dijk, K.W.9
  • 39
    • 77649336543 scopus 로고    scopus 로고
    • Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation
    • Shu, X., L. Nelbach, R. O. Ryan, and T. M. Forte. 2010. Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation. Biochim. Biophys. Acta. 1801: 605-608.
    • (2010) Biochim. Biophys. Acta , vol.1801 , pp. 605-608
    • Shu, X.1    Nelbach, L.2    Ryan, R.O.3    Forte, T.M.4
  • 40
    • 4043134745 scopus 로고    scopus 로고
    • Rate of production of plasma and Very-Low-Density Lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity
    • DOI 10.1210/jc.2003-032056
    • Cohn, J. S., B. W. Patterson, K. D. Uffelman, J. Davignon, and G. Steiner. 2004. Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity. J. Clin. Endocrinol. Metab. 89: 3949-3955. (Pubitemid 39071498)
    • (2004) Journal of Clinical Endocrinology and Metabolism , vol.89 , Issue.8 , pp. 3949-3955
    • Cohn, J.S.1    Patterson, B.W.2    Uffelman, K.D.3    Davignon, J.4    Steiner, G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.